Loading
Latest filing published 24 Aug 2026 for Sensus Healthcare, Inc., €52k.
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Joseph C. Sardano in Sensus Healthcare, Inc., where the filings describe the role as chief executive. Over a trading history stretching from 29 November 2016 to 20 August 2026, the count stands at 50 filings.
On the open market, the record shows 6 purchases worth €269k and 44 sales worth €5.1M. Sales outweigh purchases by €4.8M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 1 purchase and no sales on the market.
The median purchase comes to €41k. Of 6 purchases, 6 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
The latest filing, published on 24 August 2026, reports an open-market purchase of €52k in Sensus Healthcare, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations